LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone

Journal of Drugs in Dermatology

Volumn 8, Issue 4, 2009, Pages 351-357

  Bagel, Jerry ^a  

^a Psoriasis Treatment Center of Central New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COAL TAR; PSORENT; UNCLASSIFIED DRUG; KERATOLYTIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC PLAQUE PSORIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHEMA; FEMALE; HUMAN; MALE; NARROWBAND ULTRAVIOLET B; PHOTOTHERAPY; PILOT STUDY; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYMPTOM; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PSORIASIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; COAL TAR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; PSORIASIS; SINGLE-BLIND METHOD; ULTRAVIOLET THERAPY;

EID: 79751522327     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bhalerao J, Bowcock AM. The genetics of psoriasis: A complex disorder of the skin and immune system. Hum Mol Genet. 1998;7(10):1537-1545. (Pubitemid 28464030)
2. Simonetti O, Lucarini G, Goteri G, et al. VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: Results of an immunohistochemical study. Int J Immunopathol Pharmacol. 2006;19(4):751-760. (Pubitemid 46145039)
3. Pène J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol. 2008;180(11):7423-7430.
4. Ghoreschi K, Weigert C, Röcken M. Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol. 2007;25(6):574-580. (Pubitemid 350087604)
5. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Kinetics and regulation of human keratinocyte stem cell growth in shortterm primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest. 1995;95(1): 317-327.
6. Van Ruissen F, De Jongh GJ, Zeeuwen PL, et al. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. J Cell Physiol. 1996;168(2):442-452. (Pubitemid 26308756)
7. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1: Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826-850. (Pubitemid 351509656)
8. Goeckerman, WH. The treatment of psoriasis. Northwest Med. 1925;24:229-231.
9. Goeckerman, WH. Treatment of psoriasis. Arch Dermatol Syph. 1931;24:446-450.
10. Bernd A, Wehrenberg O, Hevert F, Holzmann H. Experimental and clinical demonstration of the antiproliferative effect of a highly purified coal tar fraction in a special gel vehicle. Arzneimittelforschung. 1988;38(4):582-586. [Article in German] (Pubitemid 18091692)
11. Lowe NJ, Breeding JH, Wortzman MS. New coal tar extract and coal tar shampoos. Evaluation by epidermal cell DNA synthesis suppression assay. Arch Dermatol. 1982;118(17):487-489. (Pubitemid 12078114)
12. Finch PW, Murphy F, Cardinale I, Krueger JG. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathol. 1997;151(6):1619-1628. (Pubitemid 27527924)
13. Krueger JG, Wolfe JT, Nabeya RT, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med. 1995;182(6):2057-2068.
14. Ozawa M, Ferenczi K, Kikuchi T, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med. 1999;189(4):711-718. (Pubitemid 29193372)
15. Borska L, Fiala Z, Krejsek J, et al. Cytogenetic and Immunological Changes after Dermal Exposure to Polycyclic Aromatic Hydrocarbons and UV Radiation. Physiol. Res. 2006;55(3):317-323.
16. Walters IB, Ozawa M, Cardinale I, et al. Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. Arch Dermatol. 2003;139(2):155-161. (Pubitemid 36216253)
17. Bielenberg DR, Bucana CD, Sanchez R, et al. Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol. 1998;111(5):864-872. (Pubitemid 28509331)
18. Akman A, Dicle O, Yilmaz F, et al. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB. Photodermatol Photoimmunol Photomed. 2008;24(3):123-127. (Pubitemid 351682226)
19. Arbiser JL, Govindarajan B, Battle TE, et al. Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar. J Invest Dermatol. 2006;126(6):1396-1402. (Pubitemid 43997924)
20. Andrys C, Borska L, Pohl D, et al. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy. Arch Dermatol Res. 2007;298(10):479-483. (Pubitemid 46295060)
21. Menkes A, Stern RS, Arndt KA. Psoriasis treatment with suberythemogenic ultraviolet B radiation and a coal tar extract. J Am Acad Dermatol. 1985;12(1 Pt 1):21-25. (Pubitemid 15188839)
22. Marsico AR, Eaglstein WH, Weinstein GD. Ultraviolet light and tar in the Goeckerman treatment of psoriasis. Arch Dermatol. 1976;112(9):1249-1250.
23. Frost P, Horwitz SN, Caputo RV, Berger SM. Tar gel-phototherapy for psoriasis: Combined therapy with syberythemogenic doses of fluorescent sunlamp ultraviolet radiation. Arch Dermatol. 1979;115(7):840-846. (Pubitemid 9246287)
24. Lowe NJ, Wortzman MS, Breeding J, et al. Coal tar phototherapy for psoriasis reevaluated: Erythemogenic versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar. J Am Acad Dermatol. 1983;8(6):781-789. (Pubitemid 13094695)
25. Lee E and Koo J. Modern modified 'ultra' Goeckerman therapy: A PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. J Dermatol Treat. 2005;16(2):102-107. (Pubitemid 40676909)
26. http://www.psoriasis.org/treatment/psoriasis/topicals/tar.php. Accessed on on August 21, 2008.
27. http://www.mayoclinic.org/psoriasis/rsttreatment.html. Accessed on September 22, 2008.
28. http://newmayoclinicdiet.com/patientstories/story-65.html Accessed on August 21, 2008.
29. American Medical Association. Current Procedural Terminology: CPT 2006, Professional Edition. AMA press, 2005.
30. Wu Y, Mills D, Barrett J, Bala M. Poor patient satisfaction and medication adherence among patients with psoriasis: Results from a large national survey. Psoriasis Forum 2007;13(2):1-5.
31. Simpson JF, Yelverton CB, Balkrishnan R, et al. Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis. Manag Care Interface. 2006;19:39-43. (Pubitemid 44148007)